Search
Tilia cordata pollen
go.drugbank.com/drugs/DB10954ApprovedTilia cordata pollen is the pollen of the Tilia cordata plant. Tilia cordata pollen is mainly used in allergenic testing.
Hordeum vulgare pollen
go.drugbank.com/drugs/DB10961ApprovedHordeum vulgare pollen is the pollen of the Hordeum vulgare plant. Hordeum vulgare pollen is mainly used in allergenic testing.
Pseudotsuga menziesii pollen
go.drugbank.com/drugs/DB10986ApprovedPseudotsuga menziesii pollen is the pollen of the Pseudotsuga menziesii plant. Pseudotsuga menziesii pollen is mainly used in allergenic testing.
Maclura pomifera pollen
go.drugbank.com/drugs/DB10988ApprovedMaclura pomifera pollen is the pollen of the Maclura pomifera plant. Maclura pomifera pollen is mainly used in allergenic testing.
Sulfaguanidine
go.drugbank.com/drugs/DB13726ExperimentalSulfaguanidine is a sulfonamide antibiotic with antimicrobial and antibacterial activities.[A275108]
Viralym-C
go.drugbank.com/drugs/DB17975InvestigationalViralym-C is an investigational T-cell immunotherapy developed by ViraCyte. It consists of Human Leukocyte Antigen (HLA)-matched cytomegalovirus (CMV)-specific T lymphocytes. … It was granted FDA orphan designation in January 2017 and investigated for the treatment of CMV infection.[A260291, L47241]
Aluminum zirconium pentachlorohydrate
go.drugbank.com/drugs/DB11147ApprovedAluminum zirconium pentachlorohydrate is a common active ingredient in personal care products as an antiperspirant agent. … Its main mechanism of action is through blocking the pores via formation of polymer complex and preventing sweat from leaving the body.
Products: On Duty 24 Hours Clear Protection Roll-On Anti-Perspirant DeodorantFAV-201
go.drugbank.com/drugs/DB06130ExperimentalFAV-201 is a patient-specific immunotherapy for the treatment of T-cell lymphoma.
Tengonermin
go.drugbank.com/drugs/DB16689InvestigationalTengonermin, also known as NGR-hTNF, is a vascular-targeting drug. … [A233270] A study also demonstrated that binding of the NGR-motif to CD13 determined both the homing of NGR-hTNF to tumor vessels and the increase in its antiangiogenic activity.[A233270]
LB-100
go.drugbank.com/drugs/DB15412InvestigationalLB-100 is under investigation in clinical trial NCT03886662 (A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)).